Polifarma Ilac Sanayi VE Ticaret AS

Biosimilar behemoth Alvotech has entered into an exclusive commercialization agreement with Polifarma for AVT06, a proposed biosimilar to Regeneron’s Eylea (aflibercept), in the Turkish market. Al

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Eisai Divests Asian Rights For Two